NO990701L - Behandling av vanlig forkj°lelse eller allergisk rhinitt - Google Patents
Behandling av vanlig forkj°lelse eller allergisk rhinittInfo
- Publication number
- NO990701L NO990701L NO990701A NO990701A NO990701L NO 990701 L NO990701 L NO 990701L NO 990701 A NO990701 A NO 990701A NO 990701 A NO990701 A NO 990701A NO 990701 L NO990701 L NO 990701L
- Authority
- NO
- Norway
- Prior art keywords
- allergic rhinitis
- common cold
- treatment
- serotonin
- agonist
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/94—[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2409696P | 1996-08-16 | 1996-08-16 | |
| PCT/US1997/014097 WO1998006402A1 (en) | 1996-08-16 | 1997-08-12 | Treatment of the common cold or allergic rhinitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO990701D0 NO990701D0 (no) | 1999-02-15 |
| NO990701L true NO990701L (no) | 1999-04-16 |
Family
ID=21818851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO990701A NO990701L (no) | 1996-08-16 | 1999-02-15 | Behandling av vanlig forkj°lelse eller allergisk rhinitt |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5962473A (pt) |
| EP (1) | EP0824917A3 (pt) |
| JP (1) | JP2000516233A (pt) |
| KR (1) | KR20000035789A (pt) |
| CN (1) | CN1233180A (pt) |
| AU (1) | AU716904B2 (pt) |
| BR (1) | BR9711147A (pt) |
| CA (1) | CA2263550A1 (pt) |
| CZ (1) | CZ289998B6 (pt) |
| EA (1) | EA001740B1 (pt) |
| HU (1) | HUP9902405A3 (pt) |
| IL (1) | IL128379A0 (pt) |
| NO (1) | NO990701L (pt) |
| NZ (1) | NZ334029A (pt) |
| PL (1) | PL331708A1 (pt) |
| WO (1) | WO1998006402A1 (pt) |
| YU (1) | YU7699A (pt) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1184373A4 (en) | 1999-04-20 | 2004-10-20 | Meiji Seika Kaisha | TRICYCLIC CONNECTIONS |
| US6476051B2 (en) | 1999-12-17 | 2002-11-05 | Bristol-Myers Squibb Company | Antipsychotic heterocycle compounds |
| WO2002051805A1 (de) | 2000-12-27 | 2002-07-04 | Bayer Aktiengesellschaft | Indol-derivate |
| US8048917B2 (en) | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| ES2296956T5 (es) | 2001-06-11 | 2011-07-12 | Xenoport, Inc. | Profármacos de análogos de gaba, composiciones y sus usos. |
| US7186855B2 (en) | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| US6818787B2 (en) | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
| ES2187300B1 (es) * | 2001-11-14 | 2004-06-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos. |
| WO2003059884A1 (en) | 2001-12-21 | 2003-07-24 | X-Ceptor Therapeutics, Inc. | Modulators of lxr |
| US7482366B2 (en) | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
| DE10217006A1 (de) * | 2002-04-16 | 2003-11-06 | Merck Patent Gmbh | Substituierte Indole |
| KR20060127000A (ko) * | 2003-11-17 | 2006-12-11 | 베링거 인겔하임 인터내셔날 게엠베하 | 신규한 피페리딘-치환된 인돌 유도체 또는 이의헤테로유도체 및 케모킨 수용체(ｃｃｒ-3)의 조절자로서의이의 용도 |
| US8795725B2 (en) | 2004-11-04 | 2014-08-05 | Xenoport, Inc. | GABA analog prodrug sustained release oral dosage forms |
| ATE531706T1 (de) * | 2005-04-30 | 2011-11-15 | Boehringer Ingelheim Int | Neue piperidin-substituierte indole und ihre verwendung als ccr-3-modulatoren |
| WO2008049874A1 (en) | 2006-10-27 | 2008-05-02 | Boehringer Ingelheim International Gmbh | Piperidyl-propane-thiol ccr3 modulators |
| WO2012112567A1 (en) * | 2011-02-15 | 2012-08-23 | Georgetown University | Small molecule inhibitors of agbl2 |
| WO2015015378A2 (en) * | 2013-08-02 | 2015-02-05 | Pfizer Inc. | Rorc2 inhibitors and methods of use thereof |
| WO2016120849A1 (en) | 2015-01-30 | 2016-08-04 | Pfizer Inc. | Methoxy-substituted pyrrolopyridine modulators of rorc2 and methods of use thereof |
| JP2018510131A (ja) | 2015-01-30 | 2018-04-12 | ファイザー・インク | Ｒｏｒｃ２のスルホンアミド置換インドールモジュレーターおよびその使用方法 |
| CN106045967B (zh) * | 2015-04-08 | 2020-04-21 | 广东东阳光药业有限公司 | 取代杂环化合物及其在药物上的应用 |
| CN106045966B (zh) * | 2015-04-08 | 2020-04-21 | 广东东阳光药业有限公司 | 取代杂环化合物及其在药物上的应用 |
| BR112019021992A2 (pt) | 2017-04-21 | 2020-06-09 | Kyn Therapeutics | inibidores de ahr de indol e usos dos mesmos |
| CN115784911A (zh) * | 2022-10-19 | 2023-03-14 | 山东省药学科学院 | 一种1-[2-(4-氯苯基)-乙基氨基]-2-丙醇的合成方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443451A (en) * | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
| GB9125699D0 (en) * | 1991-12-03 | 1992-01-29 | Glaxo Group Ltd | Device |
| US5698571A (en) * | 1994-10-05 | 1997-12-16 | Eli Lilly And Company | 5-HT1F mediated inhibition of neurogenic meningeal extravasation: a method for the treatment of migraine |
| US5521196A (en) * | 1994-10-05 | 1996-05-28 | Eli Lilly And Company | 5-HT1F agonists for the treatment of migraine |
| US5521197A (en) * | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
| TR199700993T1 (xx) * | 1995-03-20 | 1998-03-21 | Eli Lilly And Company | 5-ikameli-3-(1,2,3,6-tetrahidropridin-4-il)- ve 3-(piperidin-4-il)-1H-indoller: yeni 5-HT1F agonistler. |
| AU5966196A (en) * | 1995-06-08 | 1997-01-09 | Eli Lilly And Company | Methods of treating cold and allergic rhinitis |
| US5942536A (en) * | 1995-10-10 | 1999-08-24 | Eli Lilly And Company | N- 2-substituted-3-(2-aminoethyl)-1H-indol-5-YL!-Amides: new 5-HT1F agonists |
-
1997
- 1997-08-05 US US08/906,770 patent/US5962473A/en not_active Expired - Fee Related
- 1997-08-12 YU YU7699A patent/YU7699A/sh unknown
- 1997-08-12 EA EA199900206A patent/EA001740B1/ru not_active IP Right Cessation
- 1997-08-12 JP JP10509943A patent/JP2000516233A/ja active Pending
- 1997-08-12 AU AU40615/97A patent/AU716904B2/en not_active Ceased
- 1997-08-12 NZ NZ334029A patent/NZ334029A/xx unknown
- 1997-08-12 WO PCT/US1997/014097 patent/WO1998006402A1/en not_active Application Discontinuation
- 1997-08-12 BR BR9711147A patent/BR9711147A/pt unknown
- 1997-08-12 CN CN97198718A patent/CN1233180A/zh active Pending
- 1997-08-12 HU HU9902405A patent/HUP9902405A3/hu unknown
- 1997-08-12 CA CA002263550A patent/CA2263550A1/en not_active Abandoned
- 1997-08-12 KR KR1019997001285A patent/KR20000035789A/ko not_active Application Discontinuation
- 1997-08-12 PL PL97331708A patent/PL331708A1/xx unknown
- 1997-08-12 EP EP97306130A patent/EP0824917A3/en not_active Withdrawn
- 1997-08-12 CZ CZ1999440A patent/CZ289998B6/cs not_active IP Right Cessation
- 1997-08-12 IL IL12837997A patent/IL128379A0/xx unknown
-
1999
- 1999-02-15 NO NO990701A patent/NO990701L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9711147A (pt) | 1999-08-17 |
| HUP9902405A3 (en) | 2002-11-28 |
| EP0824917A3 (en) | 2000-08-30 |
| AU4061597A (en) | 1998-03-06 |
| JP2000516233A (ja) | 2000-12-05 |
| EA001740B1 (ru) | 2001-08-27 |
| CZ44099A3 (cs) | 1999-10-13 |
| CN1233180A (zh) | 1999-10-27 |
| WO1998006402A1 (en) | 1998-02-19 |
| HUP9902405A2 (hu) | 2000-04-28 |
| CA2263550A1 (en) | 1998-02-19 |
| US5962473A (en) | 1999-10-05 |
| PL331708A1 (en) | 1999-08-02 |
| EP0824917A2 (en) | 1998-02-25 |
| YU7699A (sh) | 2001-09-28 |
| KR20000035789A (ko) | 2000-06-26 |
| EA199900206A1 (ru) | 1999-08-26 |
| NZ334029A (en) | 2000-07-28 |
| CZ289998B6 (cs) | 2002-05-15 |
| IL128379A0 (en) | 2000-01-31 |
| AU716904B2 (en) | 2000-03-09 |
| NO990701D0 (no) | 1999-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO990701L (no) | Behandling av vanlig forkj°lelse eller allergisk rhinitt | |
| NO961326D0 (no) | Inhibitorer av | |
| NO951613L (no) | Ikke-peptidyl tachykinin reseptorantagonister | |
| FI954944A (fi) | Indolijohdannaisia 5-HT1-kaltaisina agonisteina käytettäväksi migreenin hoitoon | |
| NO20054343L (no) | Behandling av immunologiske lidelser ved anvendelse av agonister av interleukin-21/interleukin-21 reseptor | |
| NO20010446L (no) | Substituert anilidforbindelser og metoder | |
| DK0687268T3 (da) | Spiroazacykliske derivater som substans P-antagonister | |
| ES2176600T3 (es) | Derivado de la propiofenona y procedimientos para su preparacion. | |
| NO20056252L (no) | Terapeutiske og profylaktiske metoder for neuromuskulaere lidelser | |
| DK0668863T3 (da) | Quinuclidinderivat som substans P-antagonist | |
| EA199700119A1 (ru) | Соединения, оказывающие эффекты на системы, связанные с серотонином | |
| DK0804196T3 (da) | Anvendelse af serotoninantagonister (5HT 3) til behandling af fibromyalgia | |
| NO20052595L (no) | Sammensetninger anvendelige som inhibitorer av ROCK- og andre proteinkinaser. | |
| NO962568L (no) | Anvendelse av PLA2 inhibitorer som behandling for Alzheimers sykdom | |
| DK0782445T3 (da) | Kombination af en opioidantagonist og en selektiv serotoningenoptagelsesinhibitor til behandling af alkoholisme og alkoholafhængighed | |
| NO990522L (no) | Anvendelse av <beta>-ark mimetika som protease- og kinaseinhibatorer av transkripsjonsfaktorer | |
| NO20021830D0 (no) | Sammensetninger egnet til å forhindre og behandle forkjölelse og influensaliknende symptomer samt fremgangsmåter vedfremstilling derav | |
| BR0109211A (pt) | Compostos com atividade 5-ht1a úteis para o tratamento de distúrbios da retina externa | |
| ATE329588T1 (de) | Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns- erkrankungen | |
| DK0772604T3 (da) | Trialzolforbindelser og deres anvendelse som dopamin-D3-ligander | |
| DE69426767D1 (de) | Anti idiotypische Antikörper gegen Gonococcen und diese verwendende Verfahren und Zusammensetzungen. | |
| TR199700956T1 (xx) | Indazolkarboksamidler. | |
| CA2288650A1 (en) | A method for the treatment of mental illness in mammals and a composition therefor | |
| BR9913348A (pt) | Tratamento dos distúrbios da ansiedade | |
| EA199800858A1 (ru) | Способ лечения насморка или аллергического ринита |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |